Pharma Focus Asia
Eppendorf Bioprocess Solutions

Latest Issue
Get instant access to latest e-book

LATEST NEWSRead more...

09

Jun 2023

WestVac Biopharma Receives Emergency Use Authorisation (EUA) for Coviccine® Trivalent XBB.1.5-Recombinant COVID-19 Vaccine

WestVac Biopharma has announced that the Coviccine Trivalent XBBRecombinant COVID vaccine is being approved for Emergency Use Authorisation EUA by relevant authorities in China

08

Jun 2023

Samsung Biologics Collaborates with Pfizer

Samsung Biologics and Pfizer have recently announced a strategic partnership aimed at the longterm commercial manufacturing of Pfizers diverse portfolio of products

08

Jun 2023

Astellas Pharma and Kate Therapeutics Enter into Licence Agreement for KT430

Astellas Pharma and Kate Therapeutics announced an exclusive licence agreement for the development and commercialisation of KT

07

Jun 2023

Sol gel technologies enters into licence agreement with searchlight pharma

SolGel Technologies and Searchlight Pharma have officially signed exclusive licence agreements for the distribution and commercialisation of TWYNEO and EPSOLAY in the Canadian market

06

Jun 2023

Shanghai Fosun Pharmaceutical (Group) Partners with IFC

Shanghai Fosun Pharmaceutical Group has announced an enhanced partnership with the International Finance Corporation IFC to support healthcare delivery and outcomes in West Africa

05

Jun 2023

BiondVax Pharmaceuticals Signs Exclusive Licence Agreement to Develop and Commercialise Novel Anti-IL-17 Antibody

BiondVax Pharmaceuticals announced that it has signed an exclusive worldwide licence agreement to develop and commercialise VHH antibodies NanoAbs targeting Interleukin IL as treatments for various indications starting with psoriasis and psoriatic arthritis This collaboration involves the Max Planck...

press releasesRead more...

08

Jun 2023

Eisai Files Marketing Authorization Application For Lecanemab As Treatment For Early Alzheimer’s Disease In South Korea

Lecanemab Brand Name in the US LEQEMBI is the result of a strategic research alliance between Eisai and BioArctic Lecanemab is a humanized immunoglobulin gamma IgG monoclonal antibody directed against aggregated soluble protofibril and insoluble forms of amyloidbeta A

08

Jun 2023

Jacobio Pharma Receives IND Approval for PARP7 Inhibitor JAB-26766 in China

Jacobio Pharma HK has received IND Investigational New Drug approval of its selfdeveloped drug JAB PARP inhibitor from the Center for Drug Evaluation CDE of China Jacobio plans to initiate a Phase IIIa advanced solid tumors clinical trial in the China

07

Jun 2023

Samsung Biologics accelerates timeline of new fifth plant to be operational by April 2025

While attending the BIO International Convention Samsung Biologics KRXKS a leading contract development and manufacturing organization CDMO revealed details of the companys future expansion plan to have its new fifth plant operational by April Recently on June the company fully completed its late...

07

Jun 2023

KONICA MINOLTA-AIST Bioprocess Technology Cooperative Research Laboratory Established

Konica Minolta Inc Konica Minolta the National Institute of Advanced Industrial Science and Technology AIST and AIST Solutions Co Ltd AIST Solutions announced that they have jointly set up KONICA MINOLTAAIST Bioprocess Technology Cooperative Research Laboratory Bioprocess Research Lab

07

Jun 2023

Tianmaiyuanhe Announces IND Approval for Bispecific Antibody Drug A-337

Approval Notice issued A is a recombinant antiEpCAMCD bispecific antibody which is an openlabel doseescalation phase I study to evaluate the safety and pharmacokinetics of A in patients with advanced solid tumors Research EpCAM one of the first discovered tumorassociated antigens TAAs is upregulated...

07

Jun 2023

Livespo Represents Vietnam To Announce The World's First Spore Probiotics In Nasal Spray Form At The Bio International Convention

BIO International Convention is organized by BIO taking place from June in Boston MA It serves as a platform for biopharmaceutical companies investors and government leaders to exchange ideas present research findings and explore partnership opportunities in the field

08 - 09

Jun 2023

RNA Therapeutics

Boston, USA

12 - 13

Jun 2023

PHARMACEUTICAL MANUFACTURING

Geneva, Switzerland

13 - 14

Jun 2023

13 - 14

Jun 2023

Gene Therapy

London, UK

20 - 20

Jun 2023

USCC-2023

Unite Scientific Explores
Rome, Italy

Testing The WorldCelebrating 70 Years of Nalgene
Bora Pharmaceutical - A robust approach to analytical testing is essential
Selangor International Expo MEDIC 2023
TFS - Webinar - DynaSpin™ Single-Use Centrifuge for harvest applications
Medical Fair Thailand 2023
ThermoFisher Scientific - NEW Mobile App
CPHI & PMEC China 2023
THERMOFISHER SEA
Upm Raflatac
TFS
TFS
TFS
Charles River Laboratories - Endosafe Compendial LAL Cartridge Technology

TOP ARTICLES

  • 4

    Kinase Inhibitors as Antiviral Agents

    Thanigaimalai Pillaiyar

    Junior Research Group Leader, Pharmaceutical/Medicinal Chemistry, Tuebingen University

    Stefan Laufer

    Professor, Pharmaceutical/Medicinal Chemistry, Tuebingen University

  • 5

    Machine Learning for New Drugs

    Sneha Rai

    Computational and Structural Biology Laboratory, Department of Biological Sciences and Engineering, Netaji Subhas University of Technology.

    Venugopal Bhatia

    Computational and Structural Biology Laboratory, Department of Biological Sciences and Engineering, Netaji Subhas University of Technology

    Sonika Bhatnagar

    Computational and Structural Biology Laboratory, Department of Biological Sciences and Engineering, Netaji Subhas University of Technology

KNOWLEDGE BANK

  • Interviews

    Thomson Reuters

    Senior Vice President

    We believe publications such as Pharmafocus Asia are essential in providing professionals with insights into the dynamic and evolving trends of the Pharma industry

EDITORIAL SECTION